Discussing FDA’s Approval Process

Rosa L. DeLauro Congresswoman a keynote speaker at the American Association for the Advancement of Science (AAAS) Conference “What Evidence is Essential for New Medical Products—Implications for Patients and Health Policy” on June 13, in Washington D.C., wants to see FDA strengthen some of their policies and funding for FDA increased. …Continue reading

CDTM Helping Patients

According to the American Society of Health System Pharmacists, nearly half of graduating pharmacists pursue post graduate residency training with this number expected to increase. In addition, clinically trained pharmacists frequently pursue rigorous board certifications in pharmacotherapy, ambulatory care, diabetes management, plus others specialties. So today’s pharmacist is regarded as a medication expert and is well-prepared to collaborate with prescribers to optimize therapeutic outcomes. …Continue reading

Ideas on Healthcare Transparency

Building on their work to make Medicare cost and quality data more transparent, Senate Finance Committee Chairman Ron Wyden from Oregon and Senior Finance Committee Member Chuck Grassley from Iowa are asking providers, patients, advocates, insurers, entrepreneurs, and others for new ideas on how to improve overall transparency in healthcare. …Continue reading

D2PA Funding Tele-Genomics Program

Pennsylvania Governor Tom Corbett, reports that the Geisinger Genomics Medicine Center part of the Geisinger family is going to receive $100,000 from the “Discovered in PA-Developed in PA” (D2PA) program to help build the infrastructure for a state-of-the-art tele-genomics facility to be located in the Wilkes-Barre area. …Continue reading